Sun Pharmaceutical Industries, Inc. recalls Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ
Sun Pharmaceutical recalls 75mg Doxycycline capsules due to CGMP deviations in manufacturing. This affects Rx-only 100-count bottles with specific lot numbers. No immediate safety risk but requires product verification.
Lower-risk recall
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Contact the company & request your remedy
What happened, in plain English
Sun Pharmaceutical is recalling 75mg Doxycycline capsules that were not made under proper manufacturing standards. This means the product may not meet quality requirements, but there is no indication of immediate safety risks to consumers. Read more at govinfonow.com/recall/37328-sun-pharmaceutical-doxycycline-capsules-recall-cgmp-manufacturing-issues.
Source Summary by GovInfoNow · govinfonow.com/recall/37328-sun-pharmaceutical-doxycycline-capsules-recall-cgmp-manufacturing-issues · Updated October 5, 2026 · FDA enforcement record: FDA #D-1032-2020
Cite this page
“Sun Pharmaceutical Doxycycline Capsules Recall: CGMP Manufacturing Issues.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37328-sun-pharmaceutical-doxycycline-capsules-recall-cgmp-manufacturing-issues. Based on FDA recall #D-1032-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1032-2020%22&limit=1).
Why it’s dangerous
The capsules were produced without following Current Good Manufacturing Practice (CGMP) standards. This could mean the product does not meet quality requirements, but the recall does not indicate a risk of injury or serious health issues.
Who’s affected
Prescription holders of the 75mg Doxycycline capsules with lot number AA39490. Patients who have this specific batch may need to check if their product meets quality standards.
How to tell if you have this one
Check for the lot number AA39490 on the bottle. The product is a 75mg Doxycycline capsule, 100-count bottle, prescription-only, manufactured by Ohm Laboratories in New Brunswick, NJ.
- Brand
Sun Pharmaceutical- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide in the USA- NDC
63304-614-20, 63304-614-05, 63304-614-01, 63304-614-13, 63304-615-05, 63304-615-11, 63304-615-01, 63304-616-20, 63304-616-05, 63304-616-01, 63304-616-13, 63304-616-50
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1032-2020 | Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.; Lot #: AA39490, Exp 03/2021 | 624 bottles |
| D-1033-2020 | Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50.; Lot #: 3983720, Exp 10/2020; 3990461, 3990464, 3990465, 3990466, 3990470, Exp 11/2020; AA42499, AA42510, AA44468, AA44470, Exp 04/2021; AA55073, AA55074, AA55075, Exp 05/2021; AA61486, Exp 06/2021 | 172,320 bottles |
What to do — step by step
Check Product Details
Verify the lot number AA39490 on the 75mg Doxycycline capsules bottle.
Questions people ask
Is this product dangerous?
The recall is due to manufacturing quality issues, but there is no indication of immediate safety risks to consumers.
What should I do if I have this product?
Check the lot number on the bottle. If it matches AA39490, contact your healthcare provider for guidance.
Is there a risk of injury from this product?
The recall does not indicate a risk of injury or serious health issues.
Contact Sun Pharmaceutical
We’ve drafted a message you can send Sun Pharmaceutical to request your refund or repair — edit it as you like.
Subject: Recall D-1032-2020 — Sun Pharmaceutical Sun Pharmaceutical Hello, I own a Sun Pharmaceutical that is covered by recall D-1032-2020 from Sun Pharmaceutical. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1032-2020 (March 13, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1032-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.